Celebrex and Ileus paralytic - a phase IV clinical study of FDA data

Summary:

Ileus paralytic is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Aredia, and have Metastases to bone.

The phase IV clinical study analyzes which people have Ileus paralytic when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Ileus paralytic?

Ileus paralytic (obstruction of the intestine due to paralysis of the intestinal muscles) is found to be associated with 686 drugs and 849 conditions by eHealthMe. Check the latest studies of Ileus paralytic.

On Jul, 11, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 57 people (0.04%) have Ileus paralytic.

Among these 57 people:

How long have people been on Celebrex when they have Ileus paralytic? *

What is the gender of people who have Ileus paralytic when taking Celebrex? *

female: 71.93 %
male: 28.07 %

What is the age of people who have Ileus paralytic when taking Celebrex? *

What are other drugs people take besides Celebrex? *

What are other side effects people have besides Ileus paralytic? *

Fatigue (feeling of tiredness): 27 people, 47.37%
Anaemia (lack of blood): 27 people, 47.37%
Headache (pain in head): 27 people, 47.37%
Weight Decreased: 25 people, 43.86%
Osteonecrosis Of Jaw (death of bone of jaw): 25 people, 43.86%
Joint Pain: 25 people, 43.86%
Chest Pain: 24 people, 42.11%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 24 people, 42.11%
Dyspnea (difficult or laboured breathing): 24 people, 42.11%
Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung): 24 people, 42.11%

What are the existing conditions these people have? *

Metastases To Bone (cancer spreads to bone): 20 people, 35.09%
Intervertebral Disc Degeneration (spinal disc degeneration): 5 people, 8.77%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 5.26%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 3.51%
Depression: 2 people, 3.51%
Arrhythmias (irregular heartbeat): 1 person, 1.75%
Aspergillosis (an infection caused by a fungus called aspergillus): 1 person, 1.75%
Analgesia: 1 person, 1.75%
Constipation: 1 person, 1.75%
Asthma: 1 person, 1.75%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Ileus paralytic?

- Check whether Ileus paralytic is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Ileus paralytic treatments and more:

Ileus paralytic (6,720 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ileus paralytic:

Ileus paralytic (686 drugs)

Browse all the conditions that are associated with Ileus paralytic:

Ileus paralytic (849 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.